{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:22:38Z","timestamp":1791296558282,"version":"4.1.0"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.neuroscience.2011.02.035","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T09:53:07Z","timestamp":1298109187000},"page":"1-17","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Neurochemical basis of cannabis addiction"],"prefix":"10.1016","volume":"181","author":[{"given":"R.","family":"Maldonado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berrendero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ozaita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2011.02.035_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-6147(92)90064-D","article-title":"Neurobiology of marijuana abuse","volume":"13","author":"Abood","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(01)00873-1","article-title":"Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55,212-2","volume":"416","author":"Aceto","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1476-5381.1976.tb06957.x","article-title":"Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat","volume":"56","author":"Adams","year":"1976","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chembiol.2009.02.013","article-title":"Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain","volume":"16","author":"Ahn","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib5","series-title":"2004 National Drug Strategy Household Survey: First Results","year":"2005"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0301-0082(02)00080-1","article-title":"Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids","volume":"68","author":"Alger","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib7","series-title":"The diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) and proposed draft revisions (DSM-5)","year":"2000"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"Baker","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.tpj.6500352","article-title":"AATn repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population","volume":"6","author":"Ballon","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib11","series-title":"Comparative perception vol. I. Basics mechanims","first-page":"127","article-title":"Perception of drug effects","author":"Balster","year":"1990"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02245942","article-title":"Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats","volume":"118","author":"Barrett","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3565(25)23582-0","article-title":"Dependence on tetrahydrocannabinol in rhesus monkeys","volume":"239","author":"Beardsley","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1158136","article-title":"High impulsivity predicts the switch to compulsive cocaine-taking","volume":"320","author":"Belin","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuroscience.2011.02.035_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1369-1600.2009.00198.x","article-title":"CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis","volume":"16","author":"Benyamina","year":"2011","journal-title":"Addict Biol"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2011.02.035_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2826.2008.01676.x","article-title":"Endogenous cannabinoids: structure and metabolism","volume":"20","author":"Bisogno","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0306-4522(01)00210-X","article-title":"Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system","volume":"104","author":"Braida","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-2999(01)00766-X","article-title":"Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system","volume":"413","author":"Braida","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.10.043","article-title":"Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats","volume":"506","author":"Braida","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.yco.0000218592.00689.e5","article-title":"The cannabis withdrawal syndrome","volume":"19","author":"Budney","year":"2006","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.mcn.2006.01.008","article-title":"Chronic exposure to Delta9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas","volume":"31","author":"Butovsky","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.npp.1300848","article-title":"Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway","volume":"31","author":"Caill\u00e9","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1460-9568.2003.02409.x","article-title":"Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice","volume":"17","author":"Casta\u00f1\u00e9","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib26","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1460-9568.2007.05433.x","article-title":"Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors","volume":"25","author":"Centonze","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002130050518","article-title":"Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats","volume":"135","author":"Chaperon","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0306-4522(00)00241-4","article-title":"Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study","volume":"99","author":"Cheer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","article-title":"Delta9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis","volume":"102","author":"Chen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib30","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1111\/j.0953-816X.2004.03435.x","article-title":"DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine","volume":"19","author":"Cheng","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.mp.4000247","article-title":"Cannabinoid receptor gene (CNR1): association with i.v. drug use","volume":"2","author":"Comings","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/09540260902782745","article-title":"Cannabis use disorder: epidemiology and management","volume":"21","author":"Copeland","year":"2009","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0740-5472(01)00179-9","article-title":"A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder","volume":"21","author":"Copeland","year":"2001","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mp.4000925","article-title":"Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence","volume":"6","author":"Covault","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib37","doi-asserted-by":"crossref","first-page":"9867","DOI":"10.1523\/JNEUROSCI.21-24-09867.2001","article-title":"Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation","volume":"21","author":"Cui","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/npp.2009.141","article-title":"Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum","volume":"35","author":"De Chiara","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200402000-00001","article-title":"Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development","volume":"15","author":"De Vry","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1126\/science.1099020","article-title":"Evidence for addiction-like behavior in the rat","volume":"305","author":"Deroche-Gamonet","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib41","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2011.02.035_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: the nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib43","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2174\/092986710790980078","article-title":"Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs","volume":"17","author":"Di Marzo","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib44","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1073\/pnas.95.17.10269","article-title":"Mesolimbic dopaminergic decline after cannabinoid withdrawal","volume":"95","author":"Diana","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"Elsohly","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib48","series-title":"2009 Annual report on the state of the drugs problem in Europe","year":"2009"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib49","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/01.wnr.0000236853.40221.8e","article-title":"Cannabinoid self-administration increases dopamine release in the nucleus accumbens","volume":"17","author":"Fadda","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002130100734","article-title":"Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats","volume":"156","author":"Fattore","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1615\/CritRevNeurobiol.v16.i12.160","article-title":"Cannabinoids and reward: interactions with the opioid system","volume":"16","author":"Fattore","year":"2004","journal-title":"Crit Rev Neurobiol"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2011.02.035_bib52","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.mce.2008.02.006","article-title":"Neurobiological mechanisms of cannabinoid addiction","volume":"286","author":"Fattore","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bjp.0707465","article-title":"Cannabinoid self-administration in rats: sex differences and the influence of ovarian function","volume":"152","author":"Fattore","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1476-5381.2010.00734.x","article-title":"Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones","volume":"160","author":"Fattore","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib56","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1460-9568.2007.05470.x","article-title":"Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2","volume":"25","author":"Fattore","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1360-0443.2005.01070.x","article-title":"Cannabis use predicts future psychotic symptoms, and vice versa","volume":"100","author":"Ferdinand","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib59","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/cercor\/11.8.728","article-title":"The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study","volume":"11","author":"Ferraro","year":"2001","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1300\/J069v20n01_06","article-title":"Violent behavior as related to use of marijuana and other drugs","volume":"20","author":"Friedman","year":"2001","journal-title":"J Addict Dis"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib61","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0269881109106910","article-title":"Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","volume":"24","author":"Garc\u00eda-Guti\u00e9rrez","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib63","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors","volume":"160","author":"Garc\u00eda-Guti\u00e9rrez","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02431546","article-title":"Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol","volume":"96","author":"Gardner","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib65","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(96)00279-8","article-title":"123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors","volume":"307","author":"Gatley","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","article-title":"Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors","volume":"341","author":"Gessa","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib67","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","article-title":"Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors","volume":"22","author":"Ghozland","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib68","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib69","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1523\/JNEUROSCI.1507-10.2010","article-title":"Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs","volume":"30","author":"Good","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1476-5381.1974.tb09705.x","article-title":"The effect of delta1-tetrahydrocannabinol on the release of 3H-(\u2212)-noradrenaline from the isolated vas deferens of the rat","volume":"52","author":"Graham","year":"1974","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/09595230310001613976","article-title":"Being stoned: a review of self-reported cannabis effects","volume":"22","author":"Green","year":"2003","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib72","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1360-0443.2006.01427.x","article-title":"Dissecting the causal anatomy of the link between cannabis and other illicit drugs","volume":"101","author":"Hall","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib73","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(09)61037-0","article-title":"Adverse health effects of non-medical cannabis use","volume":"374","author":"Hall","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-010-1888-6","article-title":"Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse","volume":"211","author":"Haney","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib75","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.03.027","article-title":"Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies","volume":"80","author":"Hart","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib77","first-page":"127","article-title":"The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults","volume":"12","author":"Hartman","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13556210020040271","article-title":"The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users","volume":"6","author":"Heller","year":"2001","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.38267.664086.63","article-title":"Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people","volume":"330","author":"Henquet","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib81","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ajmg.b.30325","article-title":"Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence","volume":"141B","author":"Herman","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2003.08.102","article-title":"Serotonin and drug reward: focus on 5-HT2C receptors","volume":"480","author":"Higgins","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib83","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0006-8993(82)91016-2","article-title":"Delta 9-tetrahydrocannabinol-induced changes in beta-adrenergic receptor binding in mouse cerebral cortex","volume":"235","author":"Hillard","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib84","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3732\/ajb.91.6.966","article-title":"A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)","volume":"91","author":"Hillig","year":"2004","journal-title":"Am J Bot"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib85","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1254\/jphs.08244FP","article-title":"mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis","volume":"108","author":"Hojo","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/3-540-26573-2_2","article-title":"Cannabinoid receptor signaling","volume":"168","author":"Howlett","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib87","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib88","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.bjp.0702228","article-title":"Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol","volume":"125","author":"Hutcheson","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: a promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib90","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1349","article-title":"Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse","volume":"12","author":"Ji","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib91","series-title":"Monitoring the Future national survey results on drug use, 1975\u20132006. Volume II: college students and adults ages 19\u201345","author":"Johnston","year":"2007"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib92","unstructured":"Justinov\u00e1 Z, Ferr\u00e9 S, Redhi GH, Mascia P, Stroik J, Quarta D, Yasar S, M\u00fcller CE, Franco R, Goldberg SR (in press) Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. Addict Biol, in press."},{"key":"10.1016\/j.neuroscience.2011.02.035_bib93","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/npp.2008.21","article-title":"Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant","volume":"33","author":"Justinov\u00e1","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-003-1693-6","article-title":"The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys","volume":"173","author":"Justinov\u00e1","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00213-003-1484-0","article-title":"Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys","volume":"169","author":"Justinov\u00e1","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib96","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.neuroscience.2011.02.035_bib97","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/clpt.2010.318","article-title":"Subjective and physiological effects after controlled sativex and oral THC administration","volume":"89","author":"Karschner","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib98","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1187801","article-title":"Transition to addiction is associated with a persistent impairment in synaptic plasticity","volume":"328","author":"Kasanetz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib99","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00497855","article-title":"Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats","volume":"55","author":"Kaymakcalan","year":"1977","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-006-0475-3","article-title":"Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration","volume":"188","author":"Lecca","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib103","doi-asserted-by":"crossref","first-page":"PL3654","DOI":"10.1016\/0024-3205(96)00237-8","article-title":"Genetic differences in delta9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains","volume":"58","author":"Lepore","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib104","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0024-3205(95)00191-8","article-title":"Conditioned place preference induced by delta9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward","volume":"56","author":"Lepore","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.mp.4000670","article-title":"No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population","volume":"5","author":"Li","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-008-1157-0","article-title":"Interactions between delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception","volume":"199","author":"Li","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0091-3057(01)00514-7","article-title":"Precipitated cannabinoid withdrawal is reversed by delta(9)-tetrahydrocannabinol or clonidine","volume":"69","author":"Lichtman","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib108","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29469-6","article-title":"Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice","volume":"298","author":"Lichtman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib109","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/3-540-26573-2_24","article-title":"Cannabinoid tolerance and dependence","volume":"168","author":"Lichtman","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-008-1393-3","article-title":"Substitution profile of delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating delta9-tetrahydrocannabinol","volume":"203","author":"Lile","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib112","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1369-1600.2008.00105.x","article-title":"The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction","volume":"13","author":"L\u00f3pez-Moreno","year":"2008","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib113","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1360-0443.2003.00356.x","article-title":"A longitudinal study of the effects of adolescent cannabis use on high school completion","volume":"98","author":"Lynskey","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib114","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(04)16200-4","article-title":"Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies","volume":"363","author":"Macleod","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00254-1","article-title":"Study of cannabinoid dependence in animals","volume":"95","author":"Maldonado","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib116","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s002130050733","article-title":"The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta 9-tetrahydrocannabinol or anandamide","volume":"140","author":"Mallet","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib118","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1037\/0022-006X.72.3.455","article-title":"Brief treatments for cannabis dependence: findings from a randomized multisite trial","volume":"72","year":"2004","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib119","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02244907","article-title":"Animal models of drug craving","volume":"112","author":"Markou","year":"1993","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","article-title":"Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice","volume":"85","author":"Martellotta","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib121","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cne.903270406","article-title":"Localization of cannabinoid receptor mRNA in rat brain","volume":"327","author":"Matsuda","year":"1993","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib122","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib123","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(95)02066-7","article-title":"Aversive effects of the synthetic cannabinoid CP 55,940 in rats","volume":"53","author":"McGregor","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib124","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1360-0443.2008.02230.x","article-title":"Cannabis potency and contamination: a review of the literature","volume":"103","author":"McLaren","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib125","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.169.3945.611","article-title":"Chemical basis of hashish activity","volume":"169","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib126","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1556-4029.2010.01441.x","article-title":"Potency trends of \u03949-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008","volume":"55","author":"Mehmedic","year":"2010","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib127","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.npp.1300957","article-title":"Involvement of kappa\/dynorphin system in WIN 55,212-2 self-administration in mice","volume":"31","author":"Mendizabal","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib128","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0024-3205(86)90497-2","article-title":"The role of benzodiazepine receptors in the discriminative stimulus properties of delta-9-tetrahydrocannabinol","volume":"38","author":"Mokler","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib129","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pbio.0050269","article-title":"Genetic dissection of behavioural and autonomic effects of delta(9)-tetrahydrocannabinol in mice","volume":"5","author":"Monory","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00210-008-0337-0","article-title":"Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain","volume":"379","author":"Moranta","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib132","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(82)91123-4","article-title":"Drug reinforcement studied by use of place conditioning in rat","volume":"243","author":"Mucha","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib133","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib134","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.109.164806","article-title":"Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase","volume":"334","author":"Naidu","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib135","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1097\/00001756-199810260-00012","article-title":"CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats","volume":"9","author":"Navarro","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib136","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1016\/j.bmcl.2008.08.007","article-title":"Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels","volume":"18","author":"Nomura","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib137","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/cbdv.200790155","article-title":"Biosynthetic pathways of the endocannabinoid anandamide","volume":"4","author":"Okamoto","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib138","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/h0058775","article-title":"Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain","volume":"47","author":"Olds","year":"1954","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2007.11.009","article-title":"Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex","volume":"431","author":"Page","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1476-5381.2010.00775.x","article-title":"Animal models of cannabinoid reward","volume":"160","author":"Panlilio","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib141","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1037\/0735-7044.109.1.71","article-title":"THC-induced place and taste aversions in Lewis and Sprague\u2013Dawley rats","volume":"109","author":"Parker","year":"1995","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib142","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/0024-3205(95)00175-6","article-title":"AM630, a competitive cannabinoid receptor antagonist","volume":"56","author":"Pertwee","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","article-title":"Pharmacological actions of cannabinoids","volume":"168","author":"Pertwee","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib145","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib146","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13556210500123217","article-title":"Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops","volume":"10","author":"Pijlman","year":"2005","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib147","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib148","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archpsyc.58.10.909","article-title":"Neuropsychological performance in long-term cannabis users","volume":"58","author":"Pope","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib149","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1002\/j.1552-4604.2002.tb06002.x","article-title":"Cognitive measures in long-term cannabis users","volume":"42","author":"Pope","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib150","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib151","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00406-003-0440-7","article-title":"Alcoholism-related phenotypes and genetic variants of the CB1 receptor","volume":"253","author":"Preuss","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib152","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nn.2369","article-title":"Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling","volume":"12","author":"Puighermanal","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib153","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.npp.1301475","article-title":"Adolescent rats find repeated delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure","volume":"33","author":"Quinn","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib153a","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","article-title":"Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib154","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pbb.2007.01.010","article-title":"An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2)","volume":"86","author":"Rawls","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib156","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","article-title":"SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor","volume":"284","author":"Rinaldi-Carmona","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib157","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib158","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0024-3205(94)00585-0","article-title":"Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement","volume":"54","author":"Rodr\u00edguez de Fonseca","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib159","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"Rodr\u00edguez de Fonseca","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib160","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in mu opioid receptor patches of the rat caudate putamen nucleus","volume":"21","author":"Rodr\u00edguez","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib161","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1523\/JNEUROSCI.5346-07.2008","article-title":"Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum","volume":"28","author":"Rossi","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib162","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0091-3057(97)00485-1","article-title":"Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance","volume":"59","author":"Rowen","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib163","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib164","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1097\/00001756-200112040-00017","article-title":"CB1-cannabinoid and mu opioid receptor co-localization on postsynaptic target in the rat dorsal horn","volume":"12","author":"Salio","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib165","series-title":"Results from the 2008 National Survey on Drug Use and Health: National Findings","year":"2008"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib166","series-title":"Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings","year":"2010"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib167","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioural assessment of drug reinforcement and addictive features in rodents: an overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib168","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(97)13424-3","article-title":"Endogenous cannabinoids as an aversive or counter-rewarding system in the rat","volume":"223","author":"Sa\u00f1udo-Pe\u00f1a","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib169","first-page":"1121","article-title":"Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome","volume":"20","author":"Sa\u00f1udo-Pe\u00f1a","year":"1999","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib171","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0376-8716(01)00164-8","article-title":"Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence","volume":"65","author":"Schmidt","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib172","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","article-title":"Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core","volume":"51","author":"Schoffelmeer","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib173","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0022-3565(25)38633-7","article-title":"Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice","volume":"268","author":"Smith","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib174","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00213-004-2118-x","article-title":"Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats","volume":"179","author":"Solinas","year":"2005","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2006.03880.x","article-title":"Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats","volume":"98","author":"Solinas","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib176","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1523\/JNEUROSCI.0027-07.2007","article-title":"Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse","volume":"27","author":"Solinas","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib177","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1124\/jpet.106.116830","article-title":"Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide","volume":"321","author":"Solinas","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib178","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-010-1789-8","article-title":"Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of d(2)-induced formation of anandamide","volume":"209","author":"Solinas","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib179","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1111\/j.0953-816X.2004.03420.x","article-title":"Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of delta-9-tetrahydrocannabinol","volume":"19","author":"Solinas","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib180","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1460-9568.2004.03682.x","article-title":"Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC","volume":"20","author":"Soria","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib181","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.bjp.0705932","article-title":"CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat","volume":"143","author":"Spano","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib182","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1369-1600.2010.00218.x","article-title":"Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence","volume":"15","author":"Spiga","year":"2010","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib183","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib184","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.110.168435","article-title":"Rimonabant-induced delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs","volume":"334","author":"Stewart","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib185","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/mol.109.059030","article-title":"Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons","volume":"76","author":"Straiker","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib186","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","volume":"45","author":"Sugiura","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib187","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1054\/plef.2001.0356","article-title":"Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance","volume":"66","author":"Sugiura","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib188","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib189","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","article-title":"Effects of cannabinoids on neurotransmission","volume":"168","author":"Szabo","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(99)00384-2","article-title":"Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol","volume":"376","author":"Tanda","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib191","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80577","article-title":"Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys","volume":"3","author":"Tanda","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib192","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib193","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib194","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-2999(94)90003-5","article-title":"Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice","volume":"260","author":"Thorat","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0083-6729(09)81015-7","article-title":"Anandamide and the vanilloid receptor (TRPV1)","volume":"81","author":"T\u00f3th","year":"2009","journal-title":"Vitam Horm"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib196","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2009.10.011","article-title":"The endogenous opioid system: a common substrate in drug addiction","volume":"108","author":"Trigo","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib197","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/np50008a001","article-title":"Constituents of Cannabis sativa L","volume":"43","author":"Turner","year":"1980","journal-title":"J Nat Prod"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib198","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s002130050013","article-title":"A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice","volume":"147","author":"Valjent","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib199","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1523\/JNEUROSCI.20-24-09284.2000","article-title":"Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice","volume":"20","author":"Valverde","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib200","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib201","first-page":"951","article-title":"Drug seeking becomes compulsive after prolonged cocaine self-administration","volume":"13","author":"Vanderschuren","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/3-540-26573-2_12","article-title":"Retrograde signalling by endocannabinoids","volume":"168","author":"Vaughan","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00213-005-0114-4","article-title":"Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems","volume":"182","author":"Vigano","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib204","unstructured":"Viveros MP, Marco EM, L\u00f3pez-Gallardo M, Garcia-Segura LM, Wagner EJ (in press) Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. Neurosci Biobehav Rev."},{"key":"10.1016\/j.neuroscience.2011.02.035_bib205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/1352458505070618","article-title":"Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis","volume":"12","author":"Wade","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib206","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/1352458510367462","article-title":"Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis","volume":"16","author":"Wade","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib207","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(01)00367-0","article-title":"From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol","volume":"26","author":"Wagner","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib208","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1360-0443.2009.02776.x","article-title":"The abuse potential of the synthetic cannabinoid nabilone","volume":"105","author":"Ware","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib209","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(97)01342-2","article-title":"Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems","volume":"45","author":"Welch","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0091-3057(99)00130-6","article-title":"Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination","volume":"64","author":"Wiley","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib211","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.neuropharm.2008.07.038","article-title":"Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception","volume":"55","author":"Wilson","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib212","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib213","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib214","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1301552","article-title":"Cannabinoid CB1 receptor antagonists attenuate concaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats","volume":"33","author":"Xi","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib215","doi-asserted-by":"crossref","first-page":"348S","DOI":"10.1002\/j.1552-4604.1981.tb02614.x","article-title":"Behavioral effects of levonantradol and nantradol in the rhesus monkey","volume":"21","author":"Young","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib216","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1523\/JNEUROSCI.3554-05.2006","article-title":"Two brain sites for cannabinoid reward","volume":"26","author":"Zangen","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib217","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.mp.4001560","article-title":"Human cannabinoid receptor 1: 5\u2032 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse","volume":"9","author":"Zhang","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib218","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1523\/JNEUROSCI.21-23-09499.2001","article-title":"Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice","volume":"21","author":"Zimmer","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.02.035_bib219","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.biopsych.2006.12.004","article-title":"CNR1 variation modulates risk for drug and alcohol dependence","volume":"62","author":"Zuo","year":"2007","journal-title":"Biol Psychiatry"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211002053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211002053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T20:12:09Z","timestamp":1740946329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452211002053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":213,"alternative-id":["S0306452211002053"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2011.02.035","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}